Syndrome of Inappropriate Antidiuretic Hormone Secretion and "Designer Drugs" (Ecstasy)

Articles in the same Issue

1. TABLE OF CONTENTS
2. The Roles of Placental Growth Hormone and Placental Lactogen in the Regulation of Human Fetal Growth and Development
3. Turner's Syndrome and Thyroid Disease: A Transverse Study of Pediatric Patients in Brazil
4. The Rising Incidence of Childhood Type 1 Diabetes in New South Wales, Australia
5. Prolactin Secretion Abnormalities in Patients with the "Syndrome of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity and Schwannomas" (Carney Complex)
6. Is Statural Growth Predictable in Utero? Follow-up from the Second Trimester of Gestation to the 8th Year of Life
7. Postnatal Growth in Southern Chinese Children with Symptomatic Congenital Heart Disease
8. Symptomatic versus Substitution Growth Hormone Therapy in Short Children: From Auxology Towards a Comprehensive Multidimensional Assessment of Short Stature and Related Interventions
9. Psychosocial Outcome in Growth Hormone Deficient Patients Diagnosed During Childhood
10. Nocturnal Integrated Gonadotropin Concentrations in Evaluating Pubertal Transition in Girls
11. Serum Leptin Concentrations in Children with Prader-Willi Syndrome and Non-Syndromal Obesity
12. Chronic Hypoxemia Leads to Reduced Serum IGF-I Levels in Cyanotic Congenital Heart Disease
13. Syndrome of Inappropriate Antidiuretic Hormone Secretion and "Designer Drugs" (Ecstasy)
14. Osteopenia in Children and Adolescents with Hyperprolactinemia
15. Hypothalamic Hamartoma as a Cause of Precocious Puberty in Neurofibromatosis Type 1: Patient Report
16. Insulin-like Growth Factor Serum Concentrations Reflect Insufficient Growth in a Hypoplastic Infant with Partial Trisomy 9q in the 12th Week of Life
17. FORUM AND CORRESPONDENCE. BOOK REVIEWS. CALENDAR